University of Southern California at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
University of Southern California brings 12 presentations to SITC 2026 in Phoenix. Its program centres on mRNA neoantigen vaccines and CAR T cells generated inside the body, along with checkpoint drugs given before surgery. One concrete item tracks vaccine-trained T cells that last long after personalized mRNA vaccination in pancreatic cancer.
| Organization | SITC 2026 Attendance |
|---|---|
University of Southern California Los Angeles, CA | |
A private research university in Los Angeles. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from University of Southern California
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction